Literature DB >> 11719684

PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report.

A H Kaim1, C Burger, C C Ganter, G W Goerres, E Kamel, D Weishaupt, E Dizendorf, A Schaffner, G K von Schulthess.   

Abstract

An infected cyst in autosomal dominant polycystic kidney disease was identified with a combined positron emission tomographic (PET) and computed tomographic (CT) system, an experimental setup mimicking an integrated CT-PET scanner. Image fusion of fluorine 18 fluorodeoxyglucose PET and CT images allowed exact localization of the infected cyst among many cysts identified on previous CT and magnetic resonance images. Confirmation was obtained instantly, followed by CT-guided percutaneous puncture. Integrated imaging systems hold promise for direct PET-guided puncture of areas of increased fluorodeoxyglucose uptake by using the anatomic accuracy of CT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719684     DOI: 10.1148/radiol.2213010445

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT.

Authors:  Yuji Nakamoto; Mitsuaki Tatsumi; Christian Cohade; Medhat Osman; Laura T Marshall; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-25       Impact factor: 9.236

2.  The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.

Authors:  Cheng-Chien Tsai; Chien-Sheng Tsai; Koon-Kwan Ng; Chyong-Huey Lai; Swei Hsueh; Pan-Fu Kao; Ting-Chang Chang; Ji-Hong Hong; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-21       Impact factor: 9.236

3.  Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.

Authors:  Giorgina B Piccoli; Vincenzo Arena; Valentina Consiglio; Maria Chiara Deagostini; Ettore Pelosi; Anastasios Douroukas; Daniele Penna; Giancarlo Cortese
Journal:  BMC Nephrol       Date:  2011-09-29       Impact factor: 2.388

4.  Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

Authors:  Niklaus G Schaefer; Klaus Strobel; Christian Taverna; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

5.  (18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.

Authors:  Kenzo Uchida; Hideaki Nakajima; Tsuyoshi Miyazaki; Tatsuro Tsuchida; Takayuki Hirai; Daisuke Sugita; Shuji Watanabe; Naoto Takeura; Ai Yoshida; Hidehiko Okazawa; Hisatoshi Baba
Journal:  Asian Spine J       Date:  2013-05-22

6.  Positron emission tomography: a precious tool in the challenge of the infected cysts in ADPKD.

Authors:  Giorgina Barbara Piccoli; Vincenzo Arena; Valentina Consiglio; Agostino Depascale; Maria Chiara Deagostini
Journal:  NDT Plus       Date:  2010-06-22

7.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in infected polycystic kidney disease.

Authors:  Anna N Paschali; Alexandros T Georgakopoulos; Nikoletta K Pianou; Constantinos D Anagnostopoulos
Journal:  World J Nucl Med       Date:  2015 Jan-Apr

8.  Role of dual PET/CT scanning in abdominal malignancies.

Authors:  Mannudeep K Kalra; Michael A Blake; Sanjay Saini
Journal:  Cancer Imaging       Date:  2004-07-21       Impact factor: 3.909

9.  Cyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume.

Authors:  B E P Balbo; M T Sapienza; C R Ono; S K Jayanthi; J B Dettoni; I Castro; L F Onuchic
Journal:  Braz J Med Biol Res       Date:  2014-06-13       Impact factor: 2.590

10.  Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Marie Neuville; Roland Hustinx; Jessica Jacques; Jean-Marie Krzesinski; François Jouret
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.